title: Effects of a fish oil enriched diet on aspirin intolerant asthmatic patients: a pilot study.
abstract: The effect of a fish oil enriched diet containing about 3 g of eicosapentaenoic acid was studied in 10 patients with aspirin intolerant asthma. Subjects were studied during six weeks on a control diet followed by six weeks on the fish oil diet in a single blind study design. They were asked to record their peak expiratory flow (PEF) twice daily, bronchodilator and steroid doses, and subjective ratings of pulmonary symptoms on diary cards. There were no significant changes in symptom scores over the six weeks of either the control diet or the fish oil diet. PEF values, however, were significantly lower during the fifth and sixth week of the fish oil diet than during the control diet (308 v 262 l/min week 5 and 306 v 256 l/min week 6). Bronchodilator usage was also greater during the fifth and sixth week of the fish oil diet than during the control period (12.0 v 7.4 and 13.0 v 7.4 puffs a day in weeks 5 and 6). This pilot study suggests that fish diets may have a deleterious effect on patients with aspirin intolerant asthma.
authors.affiliation: Servei de Pneumologia, Hospital Clinic, Facultad de Medicina, Barcelona, Spain.
authors.forename: C
authors.initials: C
authors.lastname: Picado
authors.forename: J A
authors.initials: JA
authors.lastname: Castillo
authors.forename: N
authors.initials: N
authors.lastname: Schinca
authors.forename: M
authors.initials: M
authors.lastname: Pujades
authors.forename: A
authors.initials: A
authors.lastname: Ordinas
authors.forename: A
authors.initials: A
authors.lastname: Coronas
authors.forename: A
authors.initials: A
authors.lastname: Agusti-Vidal
mesh_terms: D000328:Adult; D000368:Aged; D000420:Albuterol / Q000008:administration & dosage / Q000627:therapeutic use; D001241:Aspirin / Q000009:adverse effects*; D001249:Asthma / Q000097:blood / Q000139:chemically induced / Q000178:diet therapy*; D004042:Dietary Fats, Unsaturated / Q000008:administration & dosage*; D004281:Docosahexaenoic Acids; D004338:Drug Combinations; D015118:Eicosapentaenoic Acid; D005227:Fatty Acids / Q000097:blood; D005231:Fatty Acids, Unsaturated / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D005395:Fish Oils / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010366:Peak Expiratory Flow Rate; D013929:Thromboxane B2 / Q000097:blood
chemical_list: D004042:Dietary Fats, Unsaturated; D004338:Drug Combinations; D005227:Fatty Acids; D005231:Fatty Acids, Unsaturated; D005395:Fish Oils; C045153:Maxepa; D004281:Docosahexaenoic Acids; D013929:Thromboxane B2; D015118:Eicosapentaenoic Acid; D000420:Albuterol; D001241:Aspirin